I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 12 studies | 23% ± 8% | |
| non-classical monocyte | 10 studies | 32% ± 18% | |
| natural killer cell | 9 studies | 23% ± 6% | |
| CD4-positive, alpha-beta T cell | 9 studies | 25% ± 9% | |
| CD16-negative, CD56-bright natural killer cell, human | 8 studies | 24% ± 6% | |
| memory B cell | 8 studies | 20% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 24% ± 7% | |
| classical monocyte | 7 studies | 28% ± 14% | |
| T cell | 6 studies | 23% ± 9% | |
| gamma-delta T cell | 6 studies | 24% ± 6% | |
| naive B cell | 6 studies | 22% ± 5% | |
| plasmablast | 5 studies | 37% ± 20% | |
| CD8-positive, alpha-beta T cell | 5 studies | 29% ± 5% | |
| CD8-positive, alpha-beta memory T cell | 5 studies | 23% ± 4% | |
| regulatory T cell | 5 studies | 20% ± 5% | |
| plasma cell | 4 studies | 30% ± 14% | |
| CD4-positive, alpha-beta memory T cell | 4 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 19% ± 2% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 25% ± 7% | |
| myeloid cell | 3 studies | 21% ± 3% | |
| effector memory CD4-positive, alpha-beta T cell | 3 studies | 27% ± 11% | |
| T follicular helper cell | 3 studies | 22% ± 5% |
